Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Business distribution deal

TempraMed CenterWell Pharmacy Distribution Agreement

Analysis based on 6 articles · First reported Sep 23, 2026 · Last updated Sep 23, 2026

Sentiment
5
Attention
1
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The deal is a small-cap commercial milestone for TempraMed, potentially improving its U.S. distribution reach and revenue prospects, though the absence of minimum purchase commitments limits near-term earnings visibility. For Humana, the impact is marginal, as CenterWell Pharmacy adding another supplier of medication-storage devices is unlikely to materially move its financials or stock.

medical devices pharmaceuticals health insurance

TempraMed Technologies, a Canadian medical-device company trading on the CSE under VIVI, announced it entered into a distribution agreement dated August 25, 2026 with CenterWell Pharmacy, the pharmacy services brand of U.S. health insurer Humana Inc. Under the agreement, CenterWell Pharmacy is expected to distribute TempraMed's temperature-controlled medication-storage products, including VIVI Cap and VIVI Epi, in the United States. TempraMed describes itself as a global medical-device company whose patented, FDA-registered thermal-insulation devices operate without batteries or external power, designed to protect temperature-sensitive medications. The agreement contains no minimum purchase commitments, and either party may terminate it on 60 days prior written notice. TempraMed framed the deal as a step to expand its commercial presence in the United States, while cautioning that there is no assurance orders will be placed or revenue generated. The announcement was issued via press release and carried by multiple outlets on September 23, 2026.

90 TempraMed Technologies entered distribution agreement CenterWell Pharmacy
priv
TempraMed is the primary beneficiary of the distribution agreement, gaining access to CenterWell Pharmacy's U.S. distribution channel for its VIVI Cap and VIVI Epi products. The deal could support revenue growth, but the lack of minimum purchase commitments and easy termination keep the benefit uncertain.
Importance 95.0 Sentiment 25.0
priv
CenterWell Pharmacy is the distribution partner that will carry TempraMed's temperature-controlled medication-storage products in the United States. The agreement modestly broadens its product offering but carries limited financial significance for the pharmacy business.
Importance 70.0 Sentiment 5.0
stock
Humana is the parent of CenterWell Pharmacy, the pharmacy services brand entering the distribution agreement. The deal is immaterial to Humana's overall insurance and pharmacy operations and is unlikely to affect its stock.
Importance 30.0 Sentiment 2.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.